Table 3 AGREE II domain scores
From: Quality appraisal of gestational diabetes mellitus guidelines with AGREE II: a systematic review
Guidelines | Scope and Purpose | Stakeholder Involvement | Rigor of Development | Clarity of Presentation | Applicability | Editorial Independence | Overall Assessment |
|---|---|---|---|---|---|---|---|
ADA [17] | 100% | 89% | 58% | 100% | 31% | 100% | 75% |
A.N.D. [29] | 94% | 89% | 51% | 94% | 77% | 29% | 58% |
API [20] | 78% | 19% | 58% | 100% | 52% | 8% | 50% |
CDA [18] | 94% | 100% | 100% | 100% | 100% | 100% | 100% |
FIGO [26] | 100% | 81% | 55% | 100% | 100% | 100% | 67% |
IDF [25] | 89% | 47% | 45% | 100% | 100% | 50% | 67% |
NGC [21] | 92% | 81% | 63% | 100% | 71% | 100% | 67% |
NICE [19] | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
NZGG [22] | 100% | 100% | 88% | 100% | 100% | 96% | 100% |
Queensland [27] | 94% | 92% | 63% | 89% | 79% | 100% | 58% |
SIGN [23] | 100% | 100% | 97% | 100% | 100% | 100% | 100% |
CMA [24] | 58% | 25% | 25% | 44% | 52% | 8% | 33% |
HKCOG [28] | 56% | 35% | 11% | 58% | 2% | 0% | 33% |
Median ± IQR | 94% ± 11% | 89% ± 53% | 58% ± 37% | 100% ± 6% | 79% ± 48% | 100 ± 71% | 67% ± 42% |
ICC | 0.85 | 0.96 | 0.96 | 0.85 | 0.98 | 0.98 | 0.98 |